Particles for Humanity Selects Final Vitamin A Product and Process for Commercial Scale-up

Cambridge, MA (June 30th, 2022)—Particles for Humanity has selected the final product and manufacturing process for its stable form of vitamin A, PFH-VAP, that will be used in commercial scaling. This achievement is a major grant milestone, triggering a $1 million payment.